Drug Type Monoclonal antibody |
Synonyms anti-CD73 antibody(Boehringer Ingelheim), BI anti-CD73, CD73 checkpoint inhibitor(Boehringer Ingelheim) + [1] |
Target |
Action inhibitors |
Mechanism CD73 inhibitors(5-nucleotidase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | Austria | - |